CH669114A5 - Homoeopathisches arzneimittel zur behandlung von rheumatischen erkrankungen. - Google Patents
Homoeopathisches arzneimittel zur behandlung von rheumatischen erkrankungen. Download PDFInfo
- Publication number
- CH669114A5 CH669114A5 CH480486A CH480486A CH669114A5 CH 669114 A5 CH669114 A5 CH 669114A5 CH 480486 A CH480486 A CH 480486A CH 480486 A CH480486 A CH 480486A CH 669114 A5 CH669114 A5 CH 669114A5
- Authority
- CH
- Switzerland
- Prior art keywords
- diseases
- treatment
- harpagophytum
- homeopathic
- trituration
- Prior art date
Links
- 230000001632 homeopathic effect Effects 0.000 title claims 6
- 208000025747 Rheumatic disease Diseases 0.000 title claims 4
- 239000003814 drug Substances 0.000 claims 11
- 201000010099 disease Diseases 0.000 claims 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 7
- 229920000159 gelatin Polymers 0.000 claims 7
- 235000019322 gelatine Nutrition 0.000 claims 7
- 238000001665 trituration Methods 0.000 claims 7
- 238000010790 dilution Methods 0.000 claims 6
- 239000012895 dilution Substances 0.000 claims 6
- 210000001185 bone marrow Anatomy 0.000 claims 5
- 108010010803 Gelatin Proteins 0.000 claims 4
- 241000207963 Harpagophytum Species 0.000 claims 4
- 230000000694 effects Effects 0.000 claims 4
- 239000008273 gelatin Substances 0.000 claims 4
- 235000011852 gelatine desserts Nutrition 0.000 claims 4
- 239000001828 Gelatine Substances 0.000 claims 3
- 210000001188 articular cartilage Anatomy 0.000 claims 3
- 229940079593 drug Drugs 0.000 claims 3
- 238000002360 preparation method Methods 0.000 claims 3
- 239000000126 substance Substances 0.000 claims 3
- 241000254191 Harpagophytum procumbens Species 0.000 claims 2
- 239000013543 active substance Substances 0.000 claims 2
- 230000000202 analgesic effect Effects 0.000 claims 2
- 229940035676 analgesics Drugs 0.000 claims 2
- 239000000730 antalgic agent Substances 0.000 claims 2
- 229940124599 anti-inflammatory drug Drugs 0.000 claims 2
- 230000003110 anti-inflammatory effect Effects 0.000 claims 2
- 210000000845 cartilage Anatomy 0.000 claims 2
- 238000001035 drying Methods 0.000 claims 2
- 239000008187 granular material Substances 0.000 claims 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims 2
- 235000019890 Amylum Nutrition 0.000 claims 1
- 239000004475 Arginine Substances 0.000 claims 1
- 208000023275 Autoimmune disease Diseases 0.000 claims 1
- 102000008186 Collagen Human genes 0.000 claims 1
- 108010035532 Collagen Proteins 0.000 claims 1
- 206010061218 Inflammation Diseases 0.000 claims 1
- 208000012659 Joint disease Diseases 0.000 claims 1
- 206010060820 Joint injury Diseases 0.000 claims 1
- 206010067125 Liver injury Diseases 0.000 claims 1
- NIPNSKYNPDTRPC-UHFFFAOYSA-N N-[2-oxo-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 NIPNSKYNPDTRPC-UHFFFAOYSA-N 0.000 claims 1
- 108010009736 Protein Hydrolysates Proteins 0.000 claims 1
- 229920002472 Starch Polymers 0.000 claims 1
- 229940051880 analgesics and antipyretics pyrazolones Drugs 0.000 claims 1
- RWZYAGGXGHYGMB-UHFFFAOYSA-N anthranilic acid Chemical class NC1=CC=CC=C1C(O)=O RWZYAGGXGHYGMB-UHFFFAOYSA-N 0.000 claims 1
- 239000003435 antirheumatic agent Substances 0.000 claims 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims 1
- 238000004820 blood count Methods 0.000 claims 1
- 210000000988 bone and bone Anatomy 0.000 claims 1
- 230000001364 causal effect Effects 0.000 claims 1
- 229920001436 collagen Polymers 0.000 claims 1
- 239000002537 cosmetic Substances 0.000 claims 1
- 230000003412 degenerative effect Effects 0.000 claims 1
- 206010012601 diabetes mellitus Diseases 0.000 claims 1
- 229940124600 folk medicine Drugs 0.000 claims 1
- 230000002496 gastric effect Effects 0.000 claims 1
- 210000001156 gastric mucosa Anatomy 0.000 claims 1
- 231100000234 hepatic damage Toxicity 0.000 claims 1
- 230000007062 hydrolysis Effects 0.000 claims 1
- 238000006460 hydrolysis reaction Methods 0.000 claims 1
- 230000002757 inflammatory effect Effects 0.000 claims 1
- 230000004054 inflammatory process Effects 0.000 claims 1
- 210000004347 intestinal mucosa Anatomy 0.000 claims 1
- 230000008818 liver damage Effects 0.000 claims 1
- 238000012153 long-term therapy Methods 0.000 claims 1
- 239000000314 lubricant Substances 0.000 claims 1
- 235000019359 magnesium stearate Nutrition 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 238000002156 mixing Methods 0.000 claims 1
- 231100000957 no side effect Toxicity 0.000 claims 1
- 229920001592 potato starch Polymers 0.000 claims 1
- 239000003531 protein hydrolysate Substances 0.000 claims 1
- JEXVQSWXXUJEMA-UHFFFAOYSA-N pyrazol-3-one Chemical class O=C1C=CN=N1 JEXVQSWXXUJEMA-UHFFFAOYSA-N 0.000 claims 1
- NDGRWYRVNANFNB-UHFFFAOYSA-N pyrazolidin-3-one Chemical class O=C1CCNN1 NDGRWYRVNANFNB-UHFFFAOYSA-N 0.000 claims 1
- 230000000552 rheumatic effect Effects 0.000 claims 1
- 229940058287 salicylic acid derivative anticestodals Drugs 0.000 claims 1
- 150000003872 salicylic acid derivatives Chemical class 0.000 claims 1
- 239000007885 tablet disintegrant Substances 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19863616054 DE3616054A1 (de) | 1986-05-13 | 1986-05-13 | Homoeopathisches arzneimittel zur behandlung von rheumatischen erkrankungen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH669114A5 true CH669114A5 (de) | 1989-02-28 |
Family
ID=6300705
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH480486A CH669114A5 (de) | 1986-05-13 | 1986-12-01 | Homoeopathisches arzneimittel zur behandlung von rheumatischen erkrankungen. |
Country Status (2)
| Country | Link |
|---|---|
| CH (1) | CH669114A5 (enExample) |
| DE (1) | DE3616054A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4327147C2 (de) * | 1993-08-12 | 1996-12-19 | Klinge Co Chem Pharm Fab | Arzneimittelzusammensetzung, welche neben dem Wirkstoff ein Gemisch aus Gelatine unterschiedlicher Löslichkeit enthält |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4436723A (en) * | 1980-09-24 | 1984-03-13 | Juanita Nepon | Arthritis composition of matter, and methods of preparing and utilizing same |
-
1986
- 1986-05-13 DE DE19863616054 patent/DE3616054A1/de active Granted
- 1986-12-01 CH CH480486A patent/CH669114A5/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DE3616054C2 (enExample) | 1991-01-10 |
| DE3616054A1 (de) | 1987-11-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0254289B1 (de) | Mittel zur Behandlung von Arthrosen | |
| EP0279382B1 (de) | Warzenmittel | |
| EP3525769B1 (de) | Schmelztablette enthaltend burlulipase und daraus hergestellte pharmazeutische zusammensetzung | |
| DE112011102356T5 (de) | Pharmazeutische Kombinationszusammensetzung und Verfahren zur Behandlung von Erkrankungen oder Zuständen, die mit dem Herz-Kreislauf-System in Verbindung stehen | |
| DE3348163C2 (enExample) | ||
| DE69804466T2 (de) | Robinia pseudoacacia lektin und seine verwendungen | |
| EP0164571A2 (de) | Retardformen des alpha-(2,5-Dimethoxy-phenyl)-beta-lycinamido-äthanols und Verfahren zu ihrer Herstellung | |
| CH669114A5 (de) | Homoeopathisches arzneimittel zur behandlung von rheumatischen erkrankungen. | |
| Makanjuola et al. | Yoruba traditional healers in psychiatry. II. Management of psychiatric disorders. | |
| DE202008015430U1 (de) | Zusammensetzung zur Behandlung von Verdauungsstörungen | |
| RU2070409C1 (ru) | Препарат для лечения мастита у лактирующих животных | |
| AT383270B (de) | Verfahren zur herstellung von oralen retardformen des alpha-(2,5-dimethoxy-phenyl)-betaglycinamido|thanols | |
| DE2657382A1 (de) | Orales antidiabetikmittel | |
| DE3905033C2 (enExample) | ||
| DE4300969A1 (enExample) | ||
| DE69911427T2 (de) | Komprimierte zusammensetzungen mit geklärter xanthangummi | |
| EP0983080B1 (de) | Synthetische, statistische thymuspeptid-kombination und deren verwendung als immunologisch und/oder endokrinologisch wirkendes praparat | |
| DE60121142T2 (de) | Zusammensetzung die paracetamol und niflumic säure enthält | |
| CN1063333C (zh) | 一种涂擦剂及其制法 | |
| DE3925759A1 (de) | Verwendung von ace-inhibitoren fuer die atheroskleroseprophylaxe | |
| EP1210945B1 (de) | Arzneimittelzubereitung mit antiarteriosklerotischer Wirkung | |
| DE102010024359B4 (de) | Arznei- oder Nahrungsergänzungsmittel zur Behandlung und/oder Prophylaxe von Gelenkerkrankungen | |
| DE2318787A1 (de) | Mittel zur behandlung von geschwueren und gastritis und dessen herstellungsverfahren | |
| DE69723417T2 (de) | Propolis Extrakt mit verbesserter Wasserlöslichkeit | |
| DE3801900A1 (de) | Verwendung von terpen-haltigen aetherischen oelen zur bekaempfung von aids und arc, sowie sie enthaltende pharmazeutische zubereitungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PL | Patent ceased |